Luis Garza, MD
Dermatology · Baltimore, MDNPI 1427074517
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $29,450 of the $44,218 with a category attached, or 66.6%. Lilly USA, LLC accounts for 80.6% of it on its own, with 3 other manufacturers making up the rest. 2025 is the largest year on record at $35,674, 4.2 times the $8,523 reported in 2019. Among dermatology clinicians in MD with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 15 payments — averaging $2947.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$36K
- Almirall LLC$9K
- Janssen Research & Development, LLC$48
- Viiv Healthcare Company$21
Across 532 payments — averaging $919.47 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Incyte Corporation$489K
What the payments were for
- Consulting fees$29,45067%
- Travel & lodging$14,49533%
- Food & beverage$2731%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 10 | $35,626 |
| Almirall LLC | 3 | $8,523 |
| Janssen Research & Development, LLC | 1 | $48 |
| Viiv Healthcare Company | 1 | $21 |
How this compares
$44,218 in reported general payments places this provider in the 90th percentile of 306 dermatology providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Minoxidil | 14 | $244 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Baltimore
- Shawn KwatraBaltimore$1.1M
- Crystal AguhBaltimore$142K
- Tamia Harris-TryonBaltimore$128K
- Elizabeth TanziBaltimore$59K
- Sewon KangBaltimore$44K
- Sima RozatiBaltimore$35K
- Larry GastonBaltimore$27K
- Janet LinBaltimore$23K
- Julie DeutschBaltimore$10K
- Benjamin LockshinSilver Spring$4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.